BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 20238314)

  • 1. Dornase alfa for cystic fibrosis.
    Jones AP; Wallis C
    Cochrane Database Syst Rev; 2010 Mar; (3):CD001127. PubMed ID: 20238314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dornase alfa for cystic fibrosis.
    Yang C; Chilvers M; Montgomery M; Nolan SJ
    Cochrane Database Syst Rev; 2016 Apr; 4():CD001127. PubMed ID: 27043279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dornase alfa for cystic fibrosis.
    Yang C; Montgomery M
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD001127. PubMed ID: 33735508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dornase alfa for cystic fibrosis.
    Yang C; Montgomery M
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD001127. PubMed ID: 30187450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human deoxyribonuclease for cystic fibrosis.
    Jones AP; Wallis CE
    Cochrane Database Syst Rev; 2003; (3):CD001127. PubMed ID: 12917899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled mannitol for cystic fibrosis.
    Nolan SJ; Thornton J; Murray CS; Dwyer T
    Cochrane Database Syst Rev; 2015 Oct; (10):CD008649. PubMed ID: 26451533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled mannitol for cystic fibrosis.
    Nevitt SJ; Thornton J; Murray CS; Dwyer T
    Cochrane Database Syst Rev; 2020 May; 5(5):CD008649. PubMed ID: 32358807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled mannitol for cystic fibrosis.
    Nevitt SJ; Thornton J; Murray CS; Dwyer T
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD008649. PubMed ID: 29424930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deoxyribonuclease for cystic fibrosis.
    Kearney CE; Wallis CE
    Cochrane Database Syst Rev; 2000; (2):CD001127. PubMed ID: 10796748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebulised hypertonic saline for cystic fibrosis.
    Wark P; McDonald VM
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD001506. PubMed ID: 30260472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebulised hypertonic saline for cystic fibrosis.
    Wark P; McDonald VM; Smith S
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD001506. PubMed ID: 37319354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of dornase alfa inhalation for cystic fibrosis.
    Dentice R; Elkins M
    Cochrane Database Syst Rev; 2011 May; (5):CD007923. PubMed ID: 21563162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of dornase alfa inhalation for cystic fibrosis.
    Dentice R; Elkins M
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD007923. PubMed ID: 27457496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerosolized dornase alfa (rhDNase) for therapy of cystic fibrosis.
    Hodson ME
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S70-4. PubMed ID: 7881698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials.
    Mayer-Hamblett N; Ratjen F; Russell R; Donaldson SH; Riekert KA; Sawicki GS; Odem-Davis K; Young JK; Rosenbluth D; Taylor-Cousar JL; Goss CH; Retsch-Bogart G; Clancy JP; Genatossio A; O'Sullivan BP; Berlinski A; Millard SL; Omlor G; Wyatt CA; Moffett K; Nichols DP; Gifford AH;
    Lancet Respir Med; 2023 Apr; 11(4):329-340. PubMed ID: 36343646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of dornase alfa inhalation for cystic fibrosis.
    Dentice R; Elkins M
    Cochrane Database Syst Rev; 2013 Jun; (6):CD007923. PubMed ID: 23737088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA; McDonald V
    Cochrane Database Syst Rev; 2000; (2):CD001506. PubMed ID: 10796798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
    Quan JM; Tiddens HA; Sy JP; McKenzie SG; Montgomery MD; Robinson PJ; Wohl ME; Konstan MW;
    J Pediatr; 2001 Dec; 139(6):813-20. PubMed ID: 11743506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of dornase alfa inhalation for cystic fibrosis.
    Dentice R; Elkins M
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD007923. PubMed ID: 33686652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease.
    Cimmino M; Nardone M; Cavaliere M; Plantulli A; Sepe A; Esposito V; Mazzarella G; Raia V
    Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1097-101. PubMed ID: 16365224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.